Beta-Blockers May Enhance Immunotherapy for Melanoma

A chart review study suggests that pan-beta-blockers, such as propranolol, may improve outcomes in metastatic melanoma.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply